MUMBAI, India, July 13 -- Intellectual Property India has published a patent application (202418051769 A) filed by Cemm - Forschungszentrum Fr on July 05, 2024, for Mutant Calreticulin For The Diagnosis Of Myeloid Malignancies.
Inventors include Kralovics, Robert; Klampfl, Thorsten; and Gisslinger, Heinz.
The application for the patent was published on July 10, 2026, under issue no. 28/2026.
Abstract: The present invention relates to a method for diagnosing myeloid malignancy comprising determining the presence of a mutant allele of the calreticulin gene. Also genomic sequences, cDNA sequences, mRNA sequences and protein sequences of the mutant calreticulin are subject of the present invention. Further, the invention relates to medical u...